UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044687
Receipt number R000050959
Scientific Title Evaluation and prevention of diabetic osteosarcopenia in the elderly by nutritional intervention and physical activity advice: DOS study ( Diabetic OsteoSarcopenia study in the elderly): an open, single-arm, prospective, interventional study.
Date of disclosure of the study information 2021/06/28
Last modified on 2024/02/17 19:17:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation and prevention of diabetic osteosarcopenia in the elderly by nutritional intervention and physical activity advice: DOS study ( Diabetic OsteoSarcopenia study in the elderly): an open, single-arm, prospective, interventional study.

Acronym

DOS study

Scientific Title

Evaluation and prevention of diabetic osteosarcopenia in the elderly by nutritional intervention and physical activity advice: DOS study ( Diabetic OsteoSarcopenia study in the elderly): an open, single-arm, prospective, interventional study.

Scientific Title:Acronym

DOS study

Region

Japan


Condition

Condition

type 2 diabetes, osteoporosis, sarcopenia

Classification by specialty

Endocrinology and Metabolism Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation and intervention of sarcopenia and osteoporosis in elderly type 2 diabetic patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement rate of endpoints for sarcopenia, osteoporosis, diabetes, nutritional status, and fatty liver after nutritional guidance and physical activity advice

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

1.nutritional intervention
duration of intervention:18 months
frequency of intervention:4
2.physical activity advice
duration of intervention:18 months
frequency of intervention:4

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

75 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who received sufficient explanation, and gave their informed written consent voluntarily with sufficient understanding.
2. Patients aged 75 years old and over at the time of consent.
3. Patients diagnosed with type 2 diabetes based on diagnostic criteria or treatment history.

Key exclusion criteria

(1) Patients with obvious dementia or mental illness.
(2) Patients using steroids.
(3) Patients with hepatic disorder with a Child-Pugh classification of 7 points or higher, or renal dysfunction with a serum creatinine level of 2 mg / dL or higher.
(4) Heart failure with restricted physical activity (NYHA classification II or higher).
(5) Patients with significant chronic complications of diabetes (nephrosis, active proliferative retinopathy, severe autonomic neuropathy).
(6) Patients with an infectious disease corresponding to SIRS (systemic inflammatory response syndrome) or trauma with an AIS (abbreviated injury scale) score of 4 or higher.
(7) Patients who are judged to have incurable cancer.
(8) Patients with a cardiac pacemaker or implantable cardioverter-defibrillator, etc.
(9) Patients with motor paralysis of limbs due to central nervous system disease.
(10) Patients who are judged to be inappropriate for this clinical study by the person in charge of research or the research coordinator.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Suzuki

Organization

Fujita Health University School of Medicine

Division name

Department of Endocrinology, Diabetes and Metabolism

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi 470-1192, Japan.

TEL

0562-93-9242

Email

aslapin@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Takayanagi

Organization

Fujita Health University School of Medicine

Division name

Department of Endocrinology, Diabetes and Metabolism

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi 470-1192, Japan.

TEL

0562-93-9242

Homepage URL


Email

haratake@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University School of Medicine
Department of Endocrinology, Diabetes and Metabolism

Institute

Department

Personal name



Funding Source

Organization

Japan Association for Diabetes Education and Care

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University Ethics Review Committee

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi 470-1192, Japan.

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 05 Month 14 Day

Date of IRB

2021 Year 05 Month 14 Day

Anticipated trial start date

2021 Year 06 Month 28 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 06 Month 28 Day

Last modified on

2024 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050959


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name